We already demonstrated that CCL18 is highly elevated in sera of patients with non small cell lung cancer and correlates with tumor stage and overall survival in the subgroup of adenocarcinoma [21], [22]. The gene discussed is CCL18; the disease is non-small cell lung carcinoma.